Obesity

Obstructive Sleep Apnea: Pathophysiology, Comorbidities and Consequences

Volumn , Issue , 2007, Pages 355-376

  Dyken, Mark Eric ^a   Ali, Mohsin ^b   Raman, Shekar ^c   Eppen, Kim E ^c  

^a UNIVERSITY OF IOWA   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 64749099544     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (201)

1. Burwell CS, Robin ED, Whaley RD, Bickelmann AG. Extreme obesity associated with alveolar hypoventilation. A pickwickian syndrome. Am J Med 1956; 21:811-818.
2. Dickens C. The Postumous papers of the pickwick club. Chapman and Hall 1837.
3. Strohl KP, Redline S. Recognition of obstructive sleep apnea. Am J Respir Crit Care Med 1996; 154:279-289.
4. Levinson PD, McGarvey ST, Carlisle CC, et al. Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest 1993; 103:1336-1342.
5. Rajala RM, Partinene M, Sane T, et al. Obstructive sleep apnea in morbidly obese patients. J Intern Med 1991; 230:125-129.
6. Bliwise DL, Feldman DE, Bliwise NG, et al. Risk factors for sleep disordered breathing in heterogeneous geriatric populations. J Am Geriatr Soc 1987; 35:132-141.
7. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middel-aged adults. N Engl J Med 1993; 328:1230-1235.
8. Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales. Sleep apnea and sleep disruption in obese patients. Arch Intern Med 1994; 154:1705-1711.
9. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstrutive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165:1217-1239.
10. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284:3015-3021.
11. National Institutes of Health: Clinical Guidelines for the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda MD, National Institutes of Health, 1998; available at http://nhlbi.nih.gov/guidelines/obesity/ob_gdlnes.pdf.
12. Resta O, Foschino-Barbaro MP, Legari G, et al. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metabl disord 2001; 25:669-675.
13. Schwartz AR, Gold AR, Schubert N, et al. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis 1991; 144:494-498.
14. Davies RJ, Ali NJ, Stradling JR. Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. Thorax 1992; 47:101-105.
15. Grunstein RR, Sullivan CE. Hypothyroidism and sleep apnea: Mechanisms and management. Am J Med 1988; 85:775-779.
16. Pelttari L, Rauhala E, Polo O, et al. Upper airway obstruction in hypothyroidism. J Intern Med 1994; 236:177-181.
17. Stradling JR, Crosby JH. Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax 1991; 46:85-90.
18. Grunstein R, Wilcox I, Yang TS, Gould Y, Hedner J. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord 1993; 17:533-540.
19. Mortimore IL, Marshall I, Wraith PK, Sellar RJ, Douglas NJ. Neck and total body fat deposition in nonobese and obese patients with sleep apnea compared with that in control subjects. Am J Respir Crit Care Med 1998; 157:280-283.
20. Hoffstein V, Mateika S. Differences in abdominal and neck circumferences in patients with and without obstructive sleep apnoea. Eur Respir J 1992; 5:377-381.
21. Davies RJ, Stradling JR. The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apnoea syndrome. Eur Respir J 1990; 3:509-514.
22. Katz I, Stradling J, Slutsky AS, Zamel N, Hoffstein V. Do patients with obstructive sleep apnea have thick necks? Am Rev Respir Dis 1990; 141:1228-1231.
23. Kushida CA, Efron B, Guilleminault C. A predictive morphometric model for the obstructive sleep apnea syndrome. Ann Intern Med 1997; 127:581-587.
24. Netzer NC, Stoohs RA, Netzer CM, et al. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999; 131:485-491.
25. Remmers JE, deGroot WJ, Sauerland EK, et al. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978; 44:931-938.
26. Suto Y, Matsuo T, Kato T, et al. Evaluation of the pharyngeal airway in patients with sleep apnea: value of ultrafast MR imaging. AJR Am J Roentgenol 1993; 160:311-314.
27. Schwartz AR, Smith PL, Wise RA, et al. Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure. J Appl Physiol 1988; 64:535-542.
28. Gleadhill I, Schwartz A, Wise R, et al. Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea. Am Rev Respir Dis 1991; 143:1300-1303.
29. Haponik E, Smith P, Bohlman M, et al. Computerized tomography in obstructive sleep apnea: correlation of airway size with physiology during sleep and wakefulness. Am Rev Respir Dis 1983; 127:221-226.
30. Schwab RJ, Gupta KB, Gefter WB, et al. Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing. Significance of the lateral pharyngeal walls. Am J Respir Crit Care Med 1995; 152:1673-1689.
31. Zhou B, Ji C, Zhou D. Clinical study on oropharyngeal fatty infiltration on the pathogenesis of obstructive sleep apnea syndrome. Lin chauang Er Bi Yan Hou Ke Za Zhi 2003; 9:535-538.
32. Stauffer JL, Buick MK, Bixler EO, et al. Morphology of the uvula in obstructive sleep apnea. Am Rev Respir Dis 1989; 140:724-728.
33. Zohar Y, Sabo R, Strauss M, et al. Oropharyngeal fatty infiltration in obstructive sleep apnea patients: A histologic study. Ann Otol Rhinol Laryngol 1998; 107:170-174.
34. Series F, Cote C, Simoneau JA, et al. Physiologic, metabolic, and muscle fiber type characteristics of musculus uvulae in sleep apnea hypopnea syndrome and in snorers. J Clin Invest 1995; 95:20-25.
35. Shelton KE, Gay SB, Hollowell DE, et al. Mandible enclosure of upper airway and weight in obstructive sleep apnea. Am Rev Respir Dis 1993; 148:195-200.
36. Shelton KE, Woodson H, Gay S, Suratt PM. Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis 1993; 148:462-466.
37. Welch KC, Foster GD, Ritter CT, et al. A novel volumetric magnetic resonance imaging paradigm to study upper airway anatomy. Sleep 2002; 25:532-542.
38. Phillips B, Kryger MH. Management of obstructive sleep apnea-hypopnea syndrome: overview. In: Kryger MH, Roth T, Dement WC eds. Principles and practice of sleep medicine, 4th edn. Philadelphia: Elsevier Saunders, 2005:1109-1121.
39. Vgontzas AN, Bixler EO, Chrousos GP. Metabolic disturbances in obesity versus sleep apnoea: The importance of visceral obesity and insulin resistance. J Intern Med 2003; 254:32-44.
40. Despres JP. Health consequences of visceral obesity. Ann Med 2001; 33:534-541.
41. Folsom AR, Kushi LH, Anderson KE, et al. Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. Arch Intern Med 2000; 160:2117-2128.
42. American Academy of Sleep Medicine Task Force: Sleep related breathing disorders in adults: Recommendation for syndrome definition and measurement techniques in clinical research. Sleep 1992; 22:667-689.
43. Kissebach AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54:254-260.
44. Ashwell M, Cole TJ, Dixon AK. Obesity: new insight into the anthropometric classification of fat distribution shown by computed tomography. BMJ 1985; 290:1692-1694.
45. Hoffstein V, Mateika S. Differences in abdominal and neck circumferences in patients with and without obstructive sleep apnoea. Eur Respir J 1992; 5:377-381.
46. Shinohara E, Kihara S, Yamashita S, et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 1997; 241:11-18.
47. Redline S. Age-related differences in sleep apnea: Generalizability of finding in older populations. In Kuna S (ed): Sleep and Respiration in Aging Adults. New York, Elsevier, k1991; 189-194.
48. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342:1378-1384.
49. Kripke DF, Ancoli-Israel S, Klauber MR, et al. Prevalence of sleep-disordered breathing in ages 40-64 years: A population based survey. Sleep 1997; 20:65-76.
50. Ancoli-Israel S, Gehrman P, Kripke DF, et al. Long-term follow-up of sleep disordered breathing in older adults . Sleep Med 2001; 2:511-516.
51. Young T, Shahar E, Nieto FJ, et al. Predictors of sleep-disordered breathing in community dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002; 162:893-900.
52. Strohl K, Redline S. Recognition of obstructive sleep apnea. Am J Respir Crit Care Med 1996; 154:274-289.
53. Schwab RJ. Sex differences and sleep apnoea. Thorax 1999; 54:284-285.
54. Whittle AT, Marshall I, Mortimore IL, Wraith PK, Sellar RJ, Douglas NJ. Neck soft tissue and fat distribution: comparison between normal men and women by magnetic resonance imaging. Thorax 1999; 54:323-328.
55. Legat MJ. Gender-specific aspects of obesity. Int J Fertil Womens Med 1997; 42:184-197.
56. Millman RP, Carlisle CC, McGarvey St, et al. Body fat distribution and sleep apnea severity in women. Chest 1995; 107:362-366.
57. Brooks LJ, Strohl KP. Size and mechanical properties of the pharynx in healthy men and women. Am Rev Respir Dis 1992; 146:1394-1397.
58. Brown IG, Zamel N, Hoffstein V: Pharyngeal cross-sectional area in normal men and women. J Appl Physiol 1986; 61:890-895.
59. Guilleminault C, Partinen M, Hollman K, et al. Familial aggregates in obstructive sleep apnea syndrome. Chest 1995; 107:1545-1551.
60. Schwab RJ, Kuna ST, Remmers JE. Anatomy and Physiology of Upper Airway Obstruction. In: Principles and Practice of Sleep Medicine: fourth edn. Elsevier Saunders, Philadelphia, PA 2005; 983-1000.
61. Bixler EO, Vgontzas AN, Lin H-M, et al. Prevalence of sleep-disordered breathing in women. Am J Respir Crit Care Med 2001; 163:608-613.
62. Young T, Finn L, Austin D, et al. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2003; 1167:1181-1185.
63. MacDonald HM, New SA, Campbell MK, et al. Longitudinal changes in weight in perimenopausal and early post-menopausal women: Effects of dietary energy intake, energy expenditure, dietary calcium intake and hormone replacement therapy. Int J Obes 2003; 27:669-676.
64. Flegal KM, Carroll MD, Ogden, et al. Prevalence and trends in obesity among US adults, 199-2000. JAMA 2002; 288:1723-1727.
65. Block AJ, Wynne JW, Boysen PG. Sleep-disordered breathing and nocturnal oxygen desaturation in post menopausal women. Am J Med 1980; 69:75-79.
66. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003; 88:2404-2411.
67. Espeland MA, Stefanick ML, Kritz-Silverstein D, et al. Effect of postmenopausal hormone therapy on body wight and waist and hip girths. J Clin Endocrinol Metab 1997; 82:1549-1556.
68. Fogel RB, Malhotra A, Pillar G, et al. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin endocrinol Metaab 2001; 86:1175-1180.
69. Franklin KA, Holmgren PA, Jonsson F, Poromaa N, Stenlund H, Svanborg E. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest 2000; 117:137-141.
70. Guilleminault C, Querra-Salva M-A, Chowdhuri S, Poyares D. Normal pregnancy, daytime sleeping, and blood pressure. Sleep Med 2000; 1:289-297.
71. Strohl KP, Saunders NA, Feldman NT, Hallett M. Obstructive sleep apnea in family members. N Engl J Med 1978; 299(18):969-973.
72. Schwab RJ, Paristien M, Kaplan L, et al. Family aggregation of upper airway soft tissue structures in normals and patients with sleep apnea. Am J Respir Crit Care Med 2006; 173(4):453-463.
73. Snehalatha C, Viswanathan V, Ramachandran A. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care 2003; 26(5):1380-1384.
74. Inoue S, Zimmet P, eds. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Hong Kong: World Health Organization/International Obesity Task Force/ International Association for the Study of Obesity; 2000. Available at: http://www.idi.org.au/research/report_obesity.htm.
75. Deurenberg-Yap M, Schmidt G, van Staveren WA, Deurenberg P. The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes Relat Metab Disord 2000; 24:1011-1017.
76. Swinburn BA, Ley SJ, Carmichael HE, Plank LD. Body size and composition in Polynesians. Int J Obes Relat Metab Disord 1999; 23:1178-1183.
77. Craig P, Halavatau V, Comino E, Caterson I. Differences in body composition between Tongans and Australians: time to rethink the healthy weight ranges? Int J Obes Relat Metab Disord 2001; 25:1806-1814.
78. Palmer LJ, Buxbaum SG, Larkin E, Patel SR, Elston RC, Tishler PV, Redline S. A whole-genome scan for obstructive sleep apnea and obesity. Am J Hum Genet 2003; 72:340-350.
79. Palmer LJ, Buxbaum SG, Larkin EK, et al. Whole genome scan for obstructive sleep apnea and obesity in African-American families. Am J Respir Crit Care Med 2004; 169:1314-1321.
80. Patel SR, Larkin EK, Palmer LJ, et al. Shared genetic variance of sleep apnea and related metabolic traits [Abstract]. Am J Crit Care Med 2004; 169:A759.
81. Grunstein R. Endocrine disorders. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicines. 4th ed. Philadelphia: Elsevier Saunders, 2005: 1237-1245.
82. Grunstein RR, Stenlof K, Hedner J, et al. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. Int J Obes 1995; 151:410-418.
83. Grunstein RR: Metabolic aspects of sleep apnea. Sleep 1996; 19(suppl): S218-S220.
84. Ohman M, Oksanen L, Kaprio J, et al. Genome-wide linkage scan of obesity in Finnish sibpairs reveals linkage to chromosome Xq24. J Clin Endocrinol Metab 2000; 85: 3183-3190.
85. Kubin L, Tojima H, Davies RO, Pack AI. Serotonergic excitatory drive to hypoglossal motoneurons in the decerebrate cat. Neurosci Lett 1992; 139: 243-248.
86. Blundell JE, Goodson S, Halford JC. Regulation of appetite: role of leptin in signalling systems for drive and satiety. Int J Obes Relat Metab Disord 2001; 25(suppl) 1: S29-S34.
87. Heiser P, Dickhaus B, Opper C, et al. Platelet serotonin and interleukin-1 beta after sleep deprivation and recovery sleep in humans. J Neural Transm 1997; 104:1049-1058.
88. Hudgel DW, Gordon EA, Meltzer HY. Abnormal serotonergic stimulation of cortisol productiion in obstructive sleep apnea. Am J Respir Crit Care Med 1995; 152:186-192.
89. Hudgel DW, Gordon EA. Serotonin-induced cortisol release in CPAP-treated obstructive sleep apena patients. Chest 1997; 111:632-638.
90. Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999; 100:706-712.
91. Johannsson G, Marin P, Lonn L, et al Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab 1997; 83:727-734.
92. Grunstein RR, Handlesman DJ, Lawrence S, et al. Neuroendocrine dysfunction in sleep apnea: reversal by nasal continuous positive airway pressure. J clin Endocrinol Metab 1989; 68:352-358.
93. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med 2002; 53:409-435.
94. Valve R, Sivenius K, Miettinen R, et al. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women. J Clin Endocrinol Metab 1999; 84:3708-3712.
95. Yun Z, Maecker HL, Johnson RS, Giaccia AJ. Inhibition of PPAR gamma 2 gene expression by the HIF-1 regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell 2002; 2: 331-341.
96. Argyropoulos G, Harper ME. Uncoupling proteins and thermoregulation. J Appl Physiol 2002; 92:2187-2198.
97. Clement K, Ruiz J, Cassard-Doulcier AM, et al. Additive effect of A->G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta 3-adrenergic receptor gene on weight gain in morbid obesity. Int J Obes Relat Metab Disord 1996; 20:1062-1066.
98. Cirelli C, Tononi G. Uncoupling proteins and sleep deprivation. Arch Ital Biol 2004; 142:541-549.
99. Koban M, Swinson KL. Chronic REM-sleep deprivation of rats elevates metabolic rate and increases uncoupling protein-1 gene expression in brown adipose tissue. Am J Physiol Endocrinol Metab 2005; 289:E68-E74.
100. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988; 37:595-1607.
101. Kaplan NM. The deadly quartet: upper body obesity,glucose intolerance, hypertrigly-deridemia and hypertension. Arch Intern Med 1989; 149:1514-1520.
102. Coughlin SR. Mawdsley L. Mugarza JA. Calverley PM. Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25(9):735-41.
103. Peppard P, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342(19):1378-1384.
104. Vgontzas A, Papanicolaou D, Bixler E, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000; 85(3):1151-1158.
105. Ip M, Lam B, Ng M, et al. Obstructive sleep apnoea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165:670-676.
106. Kiely J, McNicholas W. Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000; 16(1):128-133.
107. Ip M, Lam K, Ho C, et al. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000; 118(3):580-586.
108. Meigs J. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000; 152(10):908-911
109. Groop L, OrOrho-Melander M. The Dysmetabolic syndrome J Intern Med 2001; 250: 105-120.
110. Coughlin S, Calverley P, Wilding J. Sleep disordered breathing: A new component of syndrome x? Obes Rev 2001; 2:267-274.
111. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. National Heart, Lung, and Blood Institute; American Heart Association. Definition of the metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109:433-438.
112. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002; 106:3143-3421.
113. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366:1059-1062.
114. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 24:1182-1186.
115. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996; 45:1455-1462.
116. Abate N.Obesity and cardiovascular disease:pathogenetic role of metabolic syndrome and therapeutic implications. J Diabetes Complications 2000; 14:154-174.
117. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation 2002; 106:2533-2536.
118. Rauscher H, Popp W, Zwick H. Systemic hypertension in snorers with and without sleep apnea. Chest 1992; 102:367-371.
119. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of association between sleep disordered breathing and hypertension. N Engl J Med 2000; 342:1378-1384.
120. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA 2000; 283:1829-1836
121. Ceddia RB, Koistinen HA, Zierath JR, Sweeney G. Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J 2002; 16:11:1163-1176.
122. Aizawa-Abe M, Ogawa Y, Masuzaki H, et al. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000; 105:1243-1252.
123. Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 2002; 39:496-501.
124. Mark AL, Correia ML, Rahmouni K, Haynes WG. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 2002; 20:1245-1250.
125. Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol 2000; 279: H234-H237.
126. Somers VK. Debating sympathetic overactivity as a hallmark of human obesity: an opposing position. J Hypertens 1999; 17:1061-1064.
127. Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens 1997; 10:S49-S55.
128. Engeli S, Sharma AM. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med 2001; 79:21-29.
129. Moller DS, Lind P, Strunge B, Pedersen EB. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003; 16:274-280.
130. O'Donnell CP, Tankersley CG, Polotsky VP, Schwartz AR, Smith PL. Leptin, obesity, and respiratory function. Respir Physiol 2000; 119:163-170.
131. Phillips BG, Hisel TM, Kato M, et al. Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens 1999; 17:1297-1300.
132. Saarelainen S, Lahtela J, Kallonen E. Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin. J Sleep Res 1997; 6:146-147.
133. Shimzu K, Chin K, Nakamura T, et al. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnea-hypopnea syndrome. Thorax 2002; 57:429-434.
134. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286:327-334.
135. Liu H, Liu J, Xiong S, et al. The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. J Tongji Med Univ 2000; 20:200-202.
136. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107:1129-1134.
137. Wolk R, Svatikova A, Nelson CA, et al. Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obesity Research 2005; 13(1):186-190.
138. Bentre J, Doebber T, Wu M, et al. Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice. Diabetes 1997; 46:1526-1531.
139. Kannel WB, Brand N, Skinner JJ Jr, Dawber TR, McNamara PM. The relation of adiposity to blood pressure and development of hypertension: the Framingham study. Ann Intern Med 1967; 67:48-59.
140. Garrison RJ, Kannel WB, Stokes J III, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987; 16:235-251.
141. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002; 166:159-165
142. Dyken ME. Cerebrovascular disease and sleep apnea. In: Bradley DT, Floras JS, eds. Sleep disorders and cardiovascular and cerebrovascular disease. Marcel Dekker Series on Lung Biology and Health in Disease. New York/Basel: Marcel Dekker, 2000: 285-306.
143. Valbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 1979; 59:959-957.
144. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 9:1897-1904.
145. Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davison DE, Somers VK. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999; 100(23):2332-2335.
146. Heitmann J, Ehlenz K, Penzel T, et al. Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 2004; 23(2):255-262.
147. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998; 98(8):772-776.
148. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993; 103:1763-1768.
149. Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998; 98: 1071-1077.
150. Narkiewicz K, Pesek CA, Kato M, Phillips BG, Davison DE, Somers VK. Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. Hypertension 1998; 32:1039-1043.
151. Dobrian AD, Davies MJ, Schriver SD, Lauterio TJ, Prewitt RL. Oxidative stress in a rat model of obesity-induced hypertension. Hypertension 2001; 37:554-560.
152. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymor-phonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162:566-570.
153. Dyugovskaya L, Lavie P, Lavie L. Increased Adhesion Molecules Expression and Production of Reactive Oxygen Species in Leukocytes of Sleep Apnea Patients. Am J Respir Crit Care Med 2002; 165:934-939.
154. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163:19-25.
155. Dyken ME, Somers VK, Yamada T, Ren ZY, Zimmerman MB. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 1996; 27:401-407.
156. Somers MJ, Harrison DG. Reactive oxygen species and the control of vasomotor tone. Curr Hypertens Rep 1999; 1:102-108.
157. Wilcox CS. Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 2002; 4:160-166.
158. Das UN. Is obesity an inflammatory condition? Nutrition 2001; 17:953-966.
159. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105:2462-2464.
160. Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275:1557-1562.
161. Lanfranchi PA, Braghiroli A, Bosimini E, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999; 99:1435-1440.
162. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation 1998; 97:2154-2159.
163. Sin DD, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999; 160:1101-1106.
164. Jood K, Jern C, Wilhelmsen L, Rosengren A. Body mass index in mid-life is associated with a first stroke in men: a prospective population study over 28 years. Stroke 2004; 35:2764-2769.
165. Kurth T, Gaziano JM, Berger K, et al. Body mass index and the risk of stroke in men. Arch Intern Med 2002; 162:2557-2562.
166. Rexrode KM, Hennekens CH, Willett WC, et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 1997; 277:1539-1545.
167. Song YM, Sung J, Davey Smith G, Ebrahim S. Body mass index and ischemic and hemorrhagic stroke: a prospective study in Korean men. Stroke 2004; 35:831-836.
168. Folsom AR, Prineas RJ, Kaye SA, Munger RG. Incidence of hypertension and stroke in relation to body fat distribution and other risk factors in older women. Stroke 1990; 21:701-706.
169. Kurth T, Gaziano JM, Rexrode KM, et al. Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation 2005; 111:1992-1998.
170. Abbott RD, Behrens GR, Sharp DS, et al. Body mass index and thromboembolic stroke in nonsmoking men in older middle age: the Honolulu Heart Program. Stroke 1994; 25:2370-2376.
171. World Health Organization: Obesity: Preventing and managing the global epidemic- Report of a WHO consultation on obesity. Geneva, World Health Organization, 1998; pp 1-276.
172. York DA, Rossner S, Caterson I, et al. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group I: worldwide demographics of obesity. Circulation 2004; 110(18):e463-e470.
173. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999; 282:1519-1522
174. Flegal K, Carroll M, Kuczmarski R, Johnson C. Overweight and obesity in the United States: Prevalence and treands, 1960-1994. Int J obes Relat Metabl Dirord 1998; 22:39-47.
175. Fontaine KR, Reddend DT, Wang C, et al. Years of life lost due to obesity. JAMA 2003; 289:187-193.
176. Peeters A, Barendregt JJ, Willekwns F, et al. Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Ann Intern Med 2003; 138:24-32.
177. Lakka H-M, Laaksonen DE, Laaka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle agedd males. JAMA 2002; 288:2709-2716.
178. Ford ES. Prevalence of the metabolic syndrome in US populations. Endocrinol Metabl Clin north Am 2004; 33:333-350.
179. Daniels SR. Cardiovascular disease risk factors and atherosclerosis in children and adolescents. Curr Atheroscler Rep 2001; 3:479-485.
180. Thompson D, Edelsberg J, Colditz GA, Bird Ap, Oster G.Lifetime health and economic consequences of obesity. Arch Intern Med 1999; 159:2177-2183.
181. U.S. Department of Health and Human Services 2001. The Surgeon General's call to action to prevent and decrease overweight and obesity. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General.
182. Wolf AM. What is the economic case for treating obesity? Obes Res 1998; 6(suppl 1): 2S-7S.
183. Thompson D, Brown JB, Nichols GA, Elmer PJ, Oster G. Body mass index and future healthcare costs: a retrospective cohort study. Obes Res 2001; 9:210-218.
184. Noseda A, Kempenaers C, Kerkhofs M, Houben JJ, Linkowski P. Sleep apnea after 1 year domiciliary nasal-continuous positive airway pressure and attempted weight reduction: potential for weaning from continuous positive airway pressure. Chest 1996; 109:138-143.
185. Kansanen M, Vanninen E, Tuunainen A, et al. The effect of a very low-calorie diet-induced weight loss on the severity of obstructive sleep apnoea and autonomic nervous function in obese patients with obstructive sleep apnoea syndrome. Clin Physiol 1998; 18:377-385.
186. Suratt PM, McTier RF, Findley LJ, Pohl SL, Wilhoit SC. Effect of very-low-calorie diets with weight loss on obstructive sleep apnea. Am J Clin Nutr 1992; 56:182S-184S.
187. Charuzi I, Ovnat A, Peiser J, Saltz H, Weitzman S, Lavie P. The effect of surgical weight reduction on sleep quality in obesity-related sleep apnea syndrome. Surgery 1985; 97:535-538.
188. Smith PL, Gold AR, Meyers DA, Haponik EF, Bleecker ER. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985; 103:850-855.
189. Dyken ME, Lin-Dyken DC, Poulton S, Zimmerman MB, Sedars E. Prospective polysomnographic analysis of obstructive sleep apnea in Down syndrome. Arch Pediatr Adolesc Med 2003; 157:655-660.
190. Ali NJ, Pitson DJ, Stradling JR. Snoring, sleep disturbance, and behaviour in 4-5 year olds. Arch Dis Child 1993; 68:360-366.
191. Loughlin GM, Wynne JW, Victorica BE. Sleep apnea as a possible cause of pulmonary hypertension in Down syndrome. J Pediatr 1981; 98:435-437.
192. Alchanatis, M, Tourkohoriti, G, Kakouros, S, et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea. Respiration 2001; 68:566-572
193. Goldstein NA, Armfield DR, Kingsley LA, Borland LM, Allen GC, Post JC. Postoperative complications after tonsillectomy and adenoidectomy in children with Down syndrome. Arch Otolaryngol Head Neck Surg 1998; 124:171-176.
194. Marcus CL, Ward SLD, Mallory GB, et al. Use of nasal continuous positive airway pressure as treatment for childhood obstructive sleep apnea. J Pediatr 1995; 127:88-94.
195. Mallory GB, Beckerman RC. Relationship between obesity and respiratory control abnormalities. In: Beckerman RC, Brouillette RT, Hunt CE, eds. Respiratory Control Disorders in Infants and Children. Baltimore Md: Williams & Wilkins 1992:294-305.
196. Nielsen KE, Nielsen DE, Lin S, et al. Changes in exercise response and tolerance following an eight week pulmonary rehabilitation program. Cardiopulmonary Physical Therapy 1997; 8:3-11.
197. Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14(5):377-381.
198. ACSM. ACSM's Guidelines for Exercise Testing and Prescriptiion. 7th ed. Baltimore, Williams & Wilkins, 2006.
199. Peker Y, Hedner J, Kraiczi H, Loth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000; 162:81-86.
200. He J, Kryger MH, Zorick FJ, Conway W, Roth TH. Mortality and apnea index in obstructive sleep apnea: experience in 385 male patients.Chest 1988; 94:9-14.
201. Partinen M, Jamieson A, Guilleminault C. Long term outcome for obstructive sleep apnea syndrome patients:mortality. Chest 1988; 1200-1204.